Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, M.
Right arrow Articles by Adachi, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, M.
Right arrow Articles by Adachi, O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 34, 22021-22027, August 21, 1998


Mutant Isolation of the Escherichia coli Quinoprotein Glucose Dehydrogenase and Analysis of Crucial Residues Asp-730 and His-775 for Its Function*

Mamoru YamadaDagger , Hisayo Inbe, Makoto Tanaka, Kenichi Sumi, Kazunobu Matsushita, and Osao Adachi

From the Department of Biological Chemistry, Faculty of Agriculture, Yamaguchi University, Yamaguchi 753-8515, Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Several mutants of quinoprotein glucose dehydrogenase (GDH) in Escherichia coli were obtained and characterized. Of these, significant mutants were further characterized by kinetic analysis after purification or by site-directed mutagenesis to introduce different amino acid substitutions. H775R and H775A showed a pronounced reduction of affinity for a prosthetic group, pyrroloquinoline quinone (PQQ), suggesting that His-775 may directly interact with PQQ. D730N and D730A showed low glucose oxidase activity without influence on the affinity for PQQ, Mg2+, or substrate, but D730R showed reduced affinity for PQQ. The spectrum of tryptophan fluorescence revealed that the local structure surrounding PQQ was not changed by D730N mutation. Based on these data, we assume that Asp-730 may occur close to PQQ and function as a proton (and also electron) donor to PQQ or acceptor from PQQH2. Substitutions of Gly-689, that are located at the end of a unique segment of GDH among homologous quinoprotein dehydrogenases, directed reduction of the affinity for PQQ or GDH activity. Therefore, the unique segment and Asp-730 may play a specific role for GDH, which might be related to the intramolecular electron transfer from PQQ to ubiquinone.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Quinoprotein GDH1 bound to the inner membrane in Escherichia coli functions in a direct oxidation of D-glucose to D-gluconate and concomitantly transferring the electrons to cytochrome oxidase through ubiquinone in the respiratory chain (1, 2). Previous reports have indicated that GDH possesses the binding sites for PQQ (3, 4), metal ions such as Mg2+ or Ca2+ (5, 6), and ubiquinone (1, 8, 9) as well as substrate glucose. The enzyme from E. coli occurs as the apoenzyme (5) because the organism is unable to produce PQQ (6), but is readily reconstituted by incubation with PQQ and the metal ions (7). To elucidate the functional structure, topological analysis has been performed (10) which revealed that GDH possesses five membrane-spanning segments at the N-terminal one-sixth portion, and that the remaining C-terminal five-sixth portion occurs at the periplasmic side of the membrane. The large C-terminal portion is assumed to have the catalytic domain including the PQQ-binding site. The binding site of ubiquinone in GDH has been proposed to be at the N-terminal hydrophobic domain of the protein (11). The ubiquinone-binding site has been indicated to be at the region close to the periplasmic side by using reconstituted proteoliposomes (10), where no membrane potential is generated by the electron transfer from glucose to ubiquinone in the dehydrogenase.

Molecular genetic and biochemical analyses of the several quinoprotein dehydrogenases including glucose, methanol, and alcohol dehydrogenases have been performed, and their primary sequences are available (12-19). Their functional structures appear to be different from each other. Unlike the monomeric and membrane-bound GDH of E. coli (1), Acinetobacter calcoaceticus, or Gluconobacter oxydans (14, 17-20), the soluble MDH of Methylobacterium organophilum XX or Paracoccus denitrificans acts as a tetramer, alpha 2beta 2, to transfer electrons to cytochrome c (13, 21, 22). Whereas, membrane-bound ADH of Acetobacter aceti occurs as a trimer, alpha beta gamma , to transfer electrons via intramolecular heme c moieties to ubiquinone (23). Alignment of the PQQ-binding protein or subunit in these dehydrogenases revealed that they have three homologous regions including the highly conserved region consisting of about 70 amino acid sequences at their C termini (20), which had been predicted as a common PQQ-binding site (16, 17). Therefore, the structure of the catalytic proteins of quinoprotein dehydrogenases may be partially similar to each other, but they transfer electrons to different components. Recently, three-dimensional structures of MDHs from three different sources of Methylophilus methylotrophus, Methylophilus W3A1, and Methylobacterium extorquens AM1 (24-26) have been determined, revealing that the amino acid residues interacting with PQQ and Ca2+ are dispersed in the whole alpha -subunit, which forms a superbarrel structure made up of eight topologically identical four-stranded antiparallel beta -sheets. On the basis of the structure, a model structure of GDH was proposed except for its N terminus and several unique segments that are absent in MDH of M. extorquens (27). However, neither direct evidence supporting the structure nor x-ray crystallography has been reported yet.

In order to identify amino acid residues crucial for GDH function, we introduced random mutagenesis that may be useful for structurally unknown enzyme. A single protein GDH is a good model to elucidate the molecular mechanism of catalytic reaction or intramolecular electron transfer of the primary dehydrogenase in the respiratory chain. This is the first report on GDH mutant isolation and characterization except for one that showed a mutant with little effect on the activity (28). We obtained several E. coli mutant GDHs, and then characterized them in respect to their glucose dehydrogenase, ubiquinone reductase, and glucose oxidase activities. Mutant GDHs with a pronounced effect on the enzyme activities were purified and their kinetic parameters were determined. The mutation effect of some mutants were further examined by introducing different amino acid substitutions. We identified at least two crucial residues, Asp-730 and His-775, possibly related to proton transfer and to binding to PQQ, respectively, to which no corresponding residue was proposed in the GDH model (27).

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Materials-- Restriction enzymes, T4 DNA ligase, Taq DNA polymerase, and the DNA sequencing kit were purchased from Takara Shuzo (Kyoto, Japan). Oligonucleotide primers were made by ourselves on a DNA synthesizer, Gene Assembler Plus (Pharmasia, Uppsala, Sweden) or by Sawady Technology (Tokyo, Japan). All other chemicals were of analytical grade.

Bacterial Strains and Plasmids-- The bacterial strains used in this study were all derivatives of E. coli K12. Their relevant genotypes and plasmids are shown in Table I. Mutations gcd::cm, insertion of the cm gene into the gcd gene encoding GDH, and Delta pts, lacking the ptsHI, from YU124 and LJ288, respectively, were transferred into W3110 by P1 transduction (32). The resulting YU245 was still able to grow on M9 glucose minimal medium (32). Thus, after N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis (32) of YU245 and penicillin screening (33), YU312 that grew very slowly on the M9 glucose medium was isolated and used for screening gcd mutants. YU312 exhibited weak red colonies on tetrazolium plates (32) containing glucose and PQQ. While, YU312 cells harboring pACGCD1 or -2, which bears the gcd gene as described below, showed white colonies on the plates.

Subcloning the gcd Gene into a Low Copy Plasmid-- To certainly obtain gcd mutants, the gcd gene on a high copy plasmid, pUCGCD1 (19), was subcloned into a low copy plasmid of a pACYC177 derivative, pACYC177-322, in which the large BamHI-PstI fragment of pACYC177 had been connected with the small BamHI-PstI fragment of pBR322. The EcoRI-PstI fragment bearing the gcd gene from pUCGCD1 was inserted into the EcoRI-PstI site of pACYC177-322, generating pACGCD1. The DraI-PstI fragment bearing the gcd gene from pUCGCD1 was inserted into the HincII-PstI site of pUC118. From the resulting pUCGCD2, the EcoRI-PstI fragment bearing the gcd gene was inserted into the EcoRI-PstI site of pACYC177-322, generating pACGCD2. The gcd gene on pACGCD1 is about 200 base pairs larger at the 5'-upstream noncoding region than that on pACGCD2. We used these two plasmids for different mutagenesis because they have different restriction sites at the 5'-upstream region. After mutagenesis, each mutated region of the gcd gene was replaced into the wild type gcd gene of pUCGCD1 to facilitate enzyme assay.

Mutagenesis-- To mutagenize the conserved C terminus from the 734th to 796th amino acid in GDH, region-specific PCR mutagenesis was performed with two primers, 5'-TTGCATGCCTGCAGGTC-3' and 5'-TTGGATCCAACAGGGTACGCTGGTC-3' in an 0.5-ml microcentrifuge tube in a final volume of 100 µl in which 0.1 nM pUCGCD1, a dNTP mixture (125 µM each of dATP, dTTP, and dGTP, and 12.5 µM dCTP, or 125 µM each of dATP, dCTP and dGTP, and 12.5 µM dTTP), 100 pmol of each oligonucleotide primer, and 2.5 units of Taq DNA polymerase were added in 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.5 mM MnCl2, 1.5 mM MgCl2, and 0.001% gelatin (w/v). Twenty-five polymerase chain reactions, each of which consisted of denaturation at 94 °C for 1 min, annealing at 55 °C for 2 min, and extension at 72 °C for 2 min, were carried out by a DNA Thermal Cycler, PJ2000 (Perkin-Elmer) as described (10). The PCR products were electrophoresed by Sea-plaque gels (Takara Shuzo) and recovered by ethanol precipitation after extraction from the gel and phenol extraction. The PCR fragments were then digested with BssHII and PstI, and inserted into the BssHII-PstI site of pACGCD2.

To mutagenize the whole region of gcd encoding GDH, in vitro mutagenesis with hydroxylamine was carried out as described (34). DNA solution (100 µl) of pACGCD1 (10 µg) in 20 mM Tris-HCl, pH 7.5, containing 1 mM EDTA was mixed with 200 µl of 0.6 M NH2OH in 40 mM K2HPO4 and 1 mM EDTA, and then incubated overnight at 37 °C. The materials were then dialyzed three times against 10 mM Tris-HCl, pH 7.5, containing 1 mM EDTA and recovered by ethanol precipitation. The plasmid DNA was used as a mutagenized DNA for transformation.

Screening of the gcd Mutants-- Mutagenized plasmid DNA was introduced into YU312, and weak red color colonies on tetrazolium plates (32) containing 0.5% glucose, 0.1 µM PQQ, and 50 µg/ml kanamycin were isolated as the gcd mutant. To avoid mutants producing immature GDHs, the isolates were then examined by Western blot using an antibody raised against GDH as described previously (35) and by measurement of GDH activity.

DNA Manipulations and Sequencing-- Conventional recombinant DNA techniques (36) were used. To determine the mutation sites, nucleotide sequencing was carried out by the dideoxy chain termination method (37) after subcloning DNA fragments into M13 mp18 or mp19 vector (38) or with the Thermo Sequenase cycle sequencing kit (Amersham, Brucks, United Kingdom). To determine the region including the mutation site of the mutants from hydroxylamine mutagenesis, recombination between the mutant gcd genes and the wild type gcd gene was performed. When the SalI-PstI fragment of the wild type gcd gene encoding the C-terminal five-sixth portion of the enzyme was replaced by corresponding mutant fragments, all recombinants showed the mutant phenotype. Further recombination experiments using two fragments produced from the SalI-PstI fragment by SmaI digestion indicated that two of them have mutation sites between the SalI and SmaI sites and the other two have between the SmaI and PstI sites. These limited regions were then subjected to nucleotide sequencing.

Site-specific Mutagenesis-- To obtain mutants, R687A, R687D, G689A, D693A, D730A, D730R, and H775A, site-specific mutagenesis was carried out using the Mutan-Super Express Km kit (Takara Shuzo). Mutagenic primers used: 5'-TGGAAGAAAGCTATTGGTAC-3'for R687A; 5'-TGGAAGAAAGATATTGGTAC-3' for R687D; 5'-AACGTATTGCTACGCCGCAG-3' for G689A; 5'-CGCCGCAGGCCAGTATGCCG-3' for D693A; 5'-GCTACGGCAGCTAACTACCT-3' for D730A; 5'-GCTACGGCACGTAACTACCT-3' for D730R; and 5'-GCAGGCGGTGCCGGTTCATT-3' for H775A. Introduced mutations were confirmed by nucleotide sequencing.

Enzyme Assay and Analytical Procedures-- Cells harboring wild type plasmid, pUCGCD1, or mutant plasmids, pUCGCDs, were grown in LB (1% Bacto-tryptone, 0.5% yeast extract, and 0.5% NaCl) containing ampicillin (100 µg/ml) for 14 h at 37 °C, harvested, and washed twice with 0.85% NaCl. The cells were then disrupted by passing twice through a French pressure cell press (16,000 p.s.i.). After removing unbroken cells by a low speed centrifuge, membrane fractions were recovered by centrifugation at 86,000 × g for 90 min. The membrane was suspended in 100 mM Tris-HCl, pH 7.0 (about 10 mg of protein/ml), for enzyme assay. PMS and Q-1 reductase activities of GDH, and glucose oxidase activity were measured as described previously (8, 10). Dehydrogenase (PMS reductase) activity was also measured with maltose, fucose, galactose, or xylose, instead of glucose, as a substrate as described previously (39). Succinate dehydrogenase (PMS reductase) activity was measured as a control by the same assay method used for GDH except that PQQ was omitted. Kinetic parameters were estimated from the Lineweaver-Burk plot drawn by using the program EnzymeKinetics (Trinity Software Technical Support, NH). Protein content was determined according to the Dulley and Grieve method (40) using bovine serum albumin as a standard. Fluorescence spectra were taken by using a Hitachi-650-10S of 1-ml samples (0.4 µM in enzyme) in 100 mM potassium phosphate, pH 7.0, containing 0.2% beta -octylgluoside and 3 mM MgCl2 in the presence or absence of 1.5 µM PQQ. Fluorescence emission was scanned from 290 to 460 nm at 25 °C with an excitation at 280 nm.

Purification of Mutant GDHs-- Four mutant GDHs with significant effect on the enzyme activity were purified according to the procedure as described previously (10). In S357L and G689D, all purification steps were performed in the presence of 10 nM PQQ to stabilize enzyme activity. Purified mutant proteins as well as wild type were analyzed by SDS-10% polyacrylamide gel electrophoresis, revealing that their purity was more than 95% homogeneity. To take fluorescence spectra, the purified protein was readsorbed to DEAE column equilibrated with 10 mM potassium phosphate, pH 7.0, containing 0.1% Triton X-100, and after washing with the same buffer in the absence of Triton, the enzyme was eluted with the same buffer containing 0.2% beta -octylgluoside.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Isolation of the gcd Mutants-- Out of 30 Gcd- mutants isolated from region-specific mutagenesis, targeting the conserved C terminus of GDH, four were found to exhibit less than 10% PMS reductase activity of the wild type. In the mutant plasmids, pACGCD2Ms, from the four mutants, the BssHII-PstI fragments corresponding to those prepared by the PCR mutagenesis were sequenced. Three of them were found to have a single mutation in the region and the remaining one has double, and all mutations except for one of the double mutants occurred at the conserved amino acid residues among GDHs of E. coli, A. calcoaceticus, and G. oxydans (Table I). Of these mutants, three mutant GDHs from pACGCD2M9, M13, and M15 were detected by Western blot analysis using an antibody against E. coli GDH but not one from pACGCD2M5 (data not shown). pACGCD2M5 has a nonsense mutation at the 765th codon in the gcd gene, resulting in producing an immature GDH presumably susceptible to intracellular proteolytic degradation. The mutated protein from pACGCD2M9 is expected to have an extra 18 amino acid residues because of mutation of the intrinsic stop codon, which was indicated as a slightly slow migration in SDS-polyacrylamide gel electrophoresis.

                              
View this table:
[in this window]
[in a new window]
 
Table I
List of strains and plasmids

Out of 32 Gcd- mutants isolated from hydroxylamine mutagenesis, four had less than 10% PMS reductase activity of the wild type. These mutants were also analyzed by Western blot to confirm producing GDH protein. To limit the region including mutation sites, recombination between the mutant gcd genes and the wild type gcd gene was performed as described under "Experimental Procedures," and the limited regions were sequenced. All mutations of the four mutants, pACGCD1N2, -3, -4, or -7, are G to A or C to T as shown in Table I, suggesting that they are derived from the hydroxylamine treatment, and all mutations occurred at conserved amino acid residues among GDHs of the three organisms.

Enzyme Activities of Mutant GDHs-- To compare the mutant GDHs with the wild type, activities of PMS reductase, Q-1 reductase, and glucose oxidase were measured with the membrane fractions (Table II). Relative GDH protein contents in the fractions were estimated by Western blot analysis (Fig. 2), and then relative PMS reductase activity was calculated based on the relative GDH contents. The results revealed that all mutant GDHs have PMS reductase activity less than 10% of the wild type, with comparable Q-1 reductase and glucose oxidase activities except for G741S and -797K (where - means a stop codon). The latter two mutant GDHs seem to retain equivalent activities of PMS reductase and glucose oxidase to those of the wild type, so their apparent reduced activities may be due to lower content of GDH in the membrane than that of the wild type. The mutant -797K reduced Q-1 reductase activity without the significant effect on Km values for PQQ and Mg2+ or on glucose oxidase activity, which reflects the normal electron transfer from GDH via intrinsic Q-8 to cytochrome oxidase. Thus, it seems that the additional C-terminal 18 amino acid residues of the mutant GDH may hamper access of the artificial Q-1, or change the conformation of the Q-1 reacting site but not of the Q-8 reacting site.

                              
View this table:
[in this window]
[in a new window]
 
Table II
PMS reductase, Q-1 reductase, and glucose oxidase activities of mutant GDHs in the membrane fractions and their kinetic properties
PMS reductase activity was measured in the presence of 33 mM glucose, 1 mM MgCl2, 0.5 µM PQQ, and 8 mM NaN3. For E742G/P757L, G689D, and H775R mutants, PQQ was added at a final concentration of 1.5 µM except that 30 µM was used for H775R. The preincubation requiring for holo-enzyme formation was performed at 25 °C for 20 min. Kinetic parameters were estimated by measuring PMS reductase activity. Ubiquinone reductase activity was measured at 25 °C by the addition of both 10 mM glucose and 50 µM Q-1 after 20-min preincubation in the presence of 1 µM PQQ and 1 mM MgCl2. Glucose oxidase activity was measured at 25 °C by the addition of 30 mM glucose after 20-min preincubation in the presence of 1 µM PQQ and 1 mM MgCl2. For G689D and H775R, PQQ was added at a final concentration of 2 and 30 µM, respectively. Reported values are the averages of two to three independent experiments performed in triplicate.

Kinetic Parameters of Mutant GDHs-- To define characteristics of the mutant GDHs, their kinetic parameters were compared with those of the wild type in the membrane fractions (Table II). S357L, G689D, and H775R showed significantly increased Km values for PQQ, and especially, H775R had 230-fold higher Km values for PQQ than wild type. P326L, G689D, G741S, and the double mutant E742G/P757L showed slightly higher Km values for Mg2+. All showed nearly the same Km value for glucose as that of wild type, indicating that no mutant appears to be affected at the substrate-binding site. Since GDH has some activities for fucose, galactose, xylose, mannose, and maltose (39), substrate specificity of the mutant GDHs was tested but no mutant showed different substrate specificity from the wild type (data not shown). Therefore, it is likely that no mutation occurs in amino acid residues related to the substrate binding, and that the mutations in these mutant GDHs may not cause total conformational changes of the protein.

Of those, four significant and intriguing mutant GDHs were subjected to purification for further characterization, in which S357L, G689D, and H775R showed much lower affinity for PQQ and D730N had reduced activities of PMS reductase and glucose oxidase but normal affinities for PQQ, Mg2+, and glucose. Both S357L and G689D were purified only when PQQ was added to solutions used in purification steps, suggesting that Ser-357 and Gly-689 are located near the PQQ-binding site and both mutations lead to a release of PQQ from the enzyme which may cause deleterious conformational change of GDH during purification. Whereas, the other two mutant GDHs could be purified in homogeneity under the condition without PQQ like the wild type. The kinetic parameters of the purified GDHs were found to be essentially the same as those obtained with the membrane fractions (Tables II and III). All four purified mutant GDHs showed Vmax less than 5% of the wild type and equivalent affinities for glucose and Mg2+ to those of the wild type, and all except for D730N were confirmed to have reduced affinity for PQQ. We thus tried to compare these mutation positions with the amino acid residues surrounding PQQ or Ca2+ in the superbarrel structure of a model GDH, which was proposed by Cozier and Anthony (27) based on the x-ray structure of the M. extorquens MDH, as follows. The model structure is formed with eight W-shaped domains consisting of four antiparallel beta -sheets and has loops a to g, of which some are specific for GDH or distinct from MDH.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Kinetic properties of purified mutant GDHs
Kinetic parameters were estimated in the presence of 33 mM glucose, 1 mM MgCl2, 0.5 µM PQQ, and 8 mM NaN3 except for material whose parameter was estimated. For mutants S357L, G689D, and H775R, PQQ was added at a final concentration of 1.5, 1.5, and 30 µM, respectively. The preincubation required for holo-enzyme formation was performed at 25 °C for 20 min.

Mutations Influencing on Affinity for PQQ-- Among the mutant GDHs, the altered amino acid residues of S357L and H775R are located close to the active site in the model. The S357L mutation influenced the affinity for PQQ but not for Mg2+, although Thr-353 beside Ser-357 hydrogen bonds to PQQ, and Asp-354 and Asn-355 to Ca2+ in the model. From these results and the evidence that S357L purification required the addition of PQQ, it is suggested that the Ser to Leu mutation in S357L may cause a local structural change and also influence the position of Thr-353 to reduce affinity for PQQ.

H775R showed an extremely reduced affinity for PQQ and low Vmax. To test whether there is a side effect by the alteration from His to Arg or not, we constructed a mutant H775A with substitution of a relatively small residue (Table IV, Fig. 3). The mutant also showed a low affinity for PQQ, but had an equivalent PMS reductase activity to that of the wild type. These results suggest that His-775 may directly interact with PQQ and that the Arg mutation but not the Ala mutation may disturb the conformation of the active site to decrease the turnover. We assume that His-775 hydrogen bonds to the C2 carboxyl group of PQQ instead of Ser-777 proposed in the model and the His-775 substitution with Arg or Ala gave rise to reduction in the affinity for PQQ. Alternatively, the substitutions may move the position of Ser-777 to weaken its hydrogen bond to PQQ.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Properties of the mutant GDHs produced by site-directed mutagenesis
Km values for PQQ of the mutant GDHs were estimated in the presence of 33 mM glucose, 1 mM MgCl2, 8 mM NaN3. The preincubation for holo-enzyme formation was performed at 25 °C for 20 min. Reported values are the averages of two independent experiments performed in triplicate.

Notably, Cleton-Jansen et al. (18) have reported that in the G. oxydans GDH, the Asn mutation from the conserved His, corresponding to His-775 in E. coli GDH, changed the substrate specificity from glucose to maltose. In the model, His-775 approaches PQQ in the active site, and the replacement of His-775 by Asn was proposed to form a more accessible active site through the funnel (27). Our experiments revealed that the Km values for maltose of H775R and H775A were 150 and 53 mM, respectively, which were slightly lower than that of the wild type GDH, being 250 mM, although their Km values for glucose were nearly the same as that of the wild type. Therefore, His-775 as proposed may be exposed to the funnel and the discrepancy between the mutants of G. oxydans and E. coli might be due to difference of the substituted residues or of residues around the His residue in each tertiary structure.

To examine the effect of the G689D mutation on affinity for PQQ, a mutant G689A was constructed and characterized (Table IV, Fig. 3). The affinity of G689A was similar to that of wild type although its PMS reductase activity was lower than that of wild type. Gly residues often form restrictive bond angles, so that the Gly substitution with other amino acid residues may perturb the local structure and adjacent residues that may have a functional role will be moved. Thus, assuming that a residue(s) close to Gly-689 may be involved in binding to PQQ, we targeted two conserved charged amino acid residues, Arg-687 and Asp-693, near Gly-689 to construct three mutants, R687A, R687D, and D693A. The former two mutant proteins were found to be low in membrane fractions and seems to be unstable. The amount of both proteins were 20 times less than that of the wild type even when the membrane fractions were prepared in the presence of PQQ and immediately subjected to electrophoresis for Western blot analysis. They could not be detected after one freeze-thaw treatment (Fig. 3 and data not shown). Because Arg-687 occurs on the outer beta -sheet, D-strand, of W6 beta -sheets (27) and its substitutions seemed to enhance degradation of GDH, the residue is assumed to stabilize the superbarrel structure presumably via ionic interaction to a residue on another beta -sheet. These mutation effects appear to be different from that of G689D or G689A because G689D in the presence of PQQ and G689A even in the absence were stable. D693A showed no effect on affinity for PQQ and on relative PMS reductase activity. Therefore, although we cannot exclude the possibility that around Gly-689 there are specific residue(s) interacting with PQQ or contributing to catalytic function, these data together with those of G698D and G689A suggest that the substituted Asp residue of G689D caused reduction of the affinity for PQQ presumably by changing the confomation around the PQQ-binding site, and that the Gly-689 in the wild type would give a crucial local structure around the residue. Notably, in the model, Gly-689 is located beside the D-strand of W6 and at the end of loop e, most of which is conserved in GDHs but absent in MDHs or ADH (Ref. 27 and see Fig. 1), so that the loop e might be important for PQQ binding in GDH.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 1.   Alignment of the C-terminal amino acid sequences of quinoprotein dehydrogenases and mutation positions of some mutant GDHs. ECO-GDH (19), ACA-GDH (14), and GOX-GDH (18) are GDHs in E. coli, A. calcoaceticus, and G. oxydans, respectively, and MEX-MDH (27) is MDH in M. extorquens. This alignment and some structural features were shown according to Ref. 27. Only C-terminal alignment is presented and protein residue numbers were shown next to the protein names. Asterisks show identical residues between the sequences of GDH in E. coli and MDH in M. extorquens. Mutation sites of three mutant GDHs obtained here are shown by boxes.

As for the mutation sites of the other three mutants, P326L, G741S, and E742G/P757L, there are no corresponding amino acid residues interacting with PQQ or Mg2+ in the model. Pro-326 occurs in the loop f of the model which is absent from MDH and P326L influenced on affinity for Mg2+ more than other mutants (Table II). Therefore, it is possible that loop f positions near the Mg2+-binding site. The mutation sites of G741S and E742G/P757L are located at the C-terminal region highly conserved in the quinoprotein dehydrogenase family, and Gly-741 and Glu-742 occur in the D-strand of W7.At the C-terminal region of the model, there are 11/2 beta -sheet W motifs with a tryptophan docking motif, but with respect to such a conservation, no specific function has been proposed, except dimerization in the case of MDH (27). Both mutations as well as -797K, which has the longer C terminus that may disturb the W8 structure, reduced the content of the mutant proteins in the membrane fractions (Fig. 2 and Table II), suggesting that the conserved region is crucial for stability of the enzyme structure. This region might also provide the interaction site for the possible N-terminal ubiquinone-binding domain in GDH or an unknown factor supporting GDH stability.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot analysis of the mutant GDHs obtained by region-specific and hydroxylamine mutageneses. The membrane fractions from YU312 containing pUCGCD1, pUC118, or pUCGCD mutants that were used for estimating various enzyme activities as shown in Table II were subjected to a SDS-10% polyacrylamide gel electrophoresis, and transferred to the blot membrane. YU312 cells containing pUCGCD1 or pUC118 were used as a positive and negative control, respectively. The wild type and mutant GDHs (GDH) were visualized using a polyclonal antibody against E. coli GDH as described previously (10). The relative amounts of the proteins were densitometrically estimated by using BIO-RAD Molecular Imager. Lanes 2-7 and 9-14 represent the membrane fractions from the positive control (wild type, 2.0 µg), the positive control (1.0 µg), G741S (12 µg), -797K (60 µg), H775R (2.0 µg), the double mutant of E742G/P757L (60 µg), the positive control (1.0 µg), the negative control (60 µg), G689D (2.0 µg), S357L (2.0 µg), D730N (2.0 µg), and P326L (2.0 µg), respectively. Lanes 1 and 8 are prestained markers, phosphorylase b (105,000) and bovine serum albumin (70, 800).

Possible Function of Asp-730-- D730N showed significantly decreased activities of PMS reductase, Q-1 reductase, and glucose oxidase, but no effect on affinity for PQQ or Mg2+ (Tables II and III). The substitution from Asp to Asn does not seem to cause a large conformational change. To further analyze the function of Asp-730, two mutants, D730A and D730R, were constructed and characterized with membrane fractions (Table IV, Fig. 3). Both mutants also showed low PMS reductase activities comparable to D730N.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 3.   Western blot analysis of the mutant GDHs obtained by site-specific mutagenesis and their stability in membrane fractions. The membrane fractions from YU312 containing pUCGCD1, pUC118, or pUCGCD mutants were used. Gel electrophoresis, blotting, and visualization were done as shown in Fig. 2. A, the mutant GDHs from site-specific mutagenesis in membrane fractions were analyzed after one freeze-thaw treatment. Lanes 1-10 represent the membrane fractions (1 µg) from the positive control (wild type) and negative control, R687A, R687D, D730A, D730R, H775A, G689A, D693A, and the positive control, respectively. B, R687A, R687D, and the wild type GDHs in membrane fractions which were freshly prepared in the presence or absence of 10 nM PQQ were analyzed. Lanes 1-6 represent the membrane fractions from the wild type (1 µg), the wild type (+ PQQ, 1 µg), R687A (10 µg), R687A (+ PQQ, 10 µg), R687D (10 µg), and R687D (+ PQQ, 10 µg), respectively. Lanes M are prestained markers.

In contrast to D730N and D730A, Km for PQQ was increased in D730R. Thus, to define whether or not the D730N mutation affects the local structure around the PQQ-binding site, we examined the local conformational change by measuring quenching of intrinsic tryptophan fluorescence induced by addition of PQQ (data not shown). Both purified apo-GDHs of D730N and the wild type exhibited the same fluorescence spectrum with an emission maximum at 338 nm when excited at 280 nm. Both fluorescence were similarly quenched by the addition of PQQ, and the quenching ratio with PQQ was similar. These results suggest that the Asp to Asn substitution at position 730 may not change the local conformation surrounding PQQ but the Arg substitution may influence the structure around the PQQ-binding site to reduce the affinity for PQQ. Asp-730 may thus be located close to the PQQ-binding site, although it occurs between beta -sheet structures in W7 of the model. Although the large difference in conformational effect was observed among Asp-730 mutants, all of them exhibited largely decreased PMS reductase activity, suggesting that Asp-730 may have a catalytic function. From these results, we assume that Asp-730 may position close to the catalytic site and is involved in proton (electron) donation to PQQ or proton extraction from PQQH2.

GDH transfers electrons directly to ubiquinone, while MDH to cytochrome c (20), and ADH to the intramolecular heme c (23), although they are proposed to share a central superbarrel structure (26, 27). They appear to have a similar configuration surrounding PQQ and the divalent cation to each other, but to evolve different segments or residues specific for the intramolecular electron transfer to the specific electron acceptor. Therefore, GDH has unique segments within the basic superbarrel structure and especially, a segment loop e in the model conserved among GDHs occurs between the conserved tryptophan docking motifs W6 and W7, where Gly-689 is located. Around loop e in the tertiary structure there is a functionally important and conserved residue, Asp-730. Thus, the residue and loop e might play a specific role for GDH from catalytic reaction to electron transfer to ubiquinone.

    ACKNOWLEDGEMENTS

We thank Drs. M. Tuda and M. H. Saier, Jr. for providing bacterial strains. We also thank M. Maeyama for technical assistance.

    FOOTNOTES

* This work was supported in part by a Grant-in Aid from the Ministry of Education, Science and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Biological Chemistry, Faculty of Agriculture, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan. Tel.: 81-839-33-5869; Fax: 81-839-33-5820; E-mail: yamada{at}agr.yamaguchi-u.ac.jp.

The abbreviations used are: GDH, glucose dehydrogenase; MDH, methanol dehydrogenase; ADH, quinohaemoprotein-cytochrome c alcohol dehydrogenaseQ-1, ubiquinone-1Q-8, ubiquinone-8PCR, polymerase chain reactionPQQ, pyrroloquinoline quinonePMS, phenazine methosulfate.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Matsushita, K., Nonobe, M., Shinagawa, E., Adachi, O., and Ameyama, M. (1987) J. Bacteriol. 169, 205-209[Abstract/Free Full Text]
  2. Van Schie, B. J., Hellingwerf, K. J., van Dijken, J. P., Elferink, M. G. L., van Dijl, J. M., Kuenen, J. G., and Konings, W. N. (1985) J. Bacteriol. 163, 493-499[Abstract/Free Full Text]
  3. Duine, J. A., Frank, J., and van Zeeland, J. K. (1979) FEBS Lett. 108, 443-446[CrossRef][Medline] [Order article via Infotrieve]
  4. Ameyama, M., Matsushita, K., Ohno, Y., Shinagawa, E., and Adachi, O. (1981) FEBS Lett. 130, 179-183[CrossRef][Medline] [Order article via Infotrieve]
  5. Hommes, R. W. J., Postma, P. W., Neijssel, O. M., Tempest, D. W., Dokter, P., and Duine, J. A. (1984) FEMS Microbiol. Lett. 24, 329-333[CrossRef]
  6. Matsushita, K., Arents, J. C., Bader, R., Yamada, M., Adachi, O., and Postma, P. W. (1997) Microbiology 143, 3149-3156[Abstract/Free Full Text]
  7. Ameyama, M., Nonobe, M., Hayashi, M., Shinagawa, E., Matsushita, K., and Adachi, O. (1985) Agric. Biol. Chem. 49, 1227-1231
  8. Matsushita, K., Shinagawa, E., Adachi, O., and Ameyama, M. (1989) J. Biochem. (Tokyo) 105, 633-637[Abstract/Free Full Text]
  9. Matsushita, K., Shinagawa, E., Adachi, O., and Ameyama, M. (1989) Biochemistry 28, 6276-6280[CrossRef][Medline] [Order article via Infotrieve]
  10. Yamada, M., Sumi, K., Matsushita, K., Adachi, O., and Yamada, Y. (1993) J. Biol. Chem. 268, 12812-12817[Abstract/Free Full Text]
  11. Friedrich, T., Strohdeicher, M., Hofhaus, G., Preis, D., Sahm, H., and Weiss, H. (1990) FEBS Lett. 265, 37-40[CrossRef][Medline] [Order article via Infotrieve]
  12. Harms, N., de Vries, G. E., Maurer, K., Hoogendijk, J., and Stouthamer, A. H. (1987) J. Bacteriol. 169, 3969-3975[Abstract/Free Full Text]
  13. Machlin, S. M., and Hanson, R. S. (1988) J. Bacteriol. 170, 4739-4747[Abstract/Free Full Text]
  14. Cleton-Jansen, A.-M., Goosen, N., Odle, G., and Van de Putte, P. (1988) Nucleic Acids Res. 16, 6228[Free Full Text]
  15. Cleton-Jansen, A.-M., Goosen, N., Vink, K., and van de Putte, P. (1989) Mol. Gen. Genet. 217, 430-436[CrossRef][Medline] [Order article via Infotrieve]
  16. Inoue, T., Sunagawa, M., Mori, A., Imai, C., Fukuda, M., Tagaki, M., and Yano, K. (1989) J. Bacteriol. 171, 3115-3122[Abstract/Free Full Text]
  17. Cleton-Jansen, A.-M., Goosen, N., Fayet, O., and van de Putte, P. (1990) J. Bacteriol. 172, 6308-6315[Abstract/Free Full Text]
  18. Cleton-Jansen, A.-M., Dekker, S., van de Putte, P., and Goosen, N. (1991) Mol. Gen. Genet. 229, 206-212[CrossRef][Medline] [Order article via Infotrieve]
  19. Yamada, M., Asaoka, S., Saier, M. H., Jr., and Yamada, Y. (1993) J. Bacteriol. 175, 568-571[Abstract/Free Full Text]
  20. Anthony, C. (1992) Int. J. Biochem. 24, 29-39[CrossRef][Medline] [Order article via Infotrieve]
  21. Anthony, C., Chan, H. T. C., Cox, J. M., and Richardson, I. W. (1993) in Microbial Growth on C1 Compounds (Murrell, J. C., and Kelly, D. P., eds), pp. 221-233, Intercept Ltd., Andover, United Kingdom
  22. Van Spanning, R. J. M., Wansell, C. W., De Boer, T., Hazelaar, M. J., Anazawa, H., Harms, N., Oltmann, L. F., and Stouthamer, A. H. (1991) J. Bacteriol. 173, 6948-6961[Abstract/Free Full Text]
  23. Matsushita, K., Yakushi, T., Toyama, H., Shinagawa, E., and Adachi, O. (1996) J. Biol. Chem. 271, 4850-4857[Abstract/Free Full Text]
  24. Xia, Z.-X., Dai, W.-W., Xiong, J.-P., Hao, Z.-P., Davidson, V. L., White, S., and Mathews, F. S. (1992) J. Biol. Chem. 267, 22289-22297[Abstract/Free Full Text]
  25. White, S., Boyd, G., Mathews, F. S., Xia, Z.-X., Dai, W.-W., Zhang, Y.-F., and Davidson, V. L. (1993) Biochemistry 32, 12955-12958[CrossRef][Medline] [Order article via Infotrieve]
  26. Blake, C. C. F., Ghosh, M., Harlos, K., Avezoux, A., and Anthony, C. (1994) Nat. Struct. Biol. 1, 102-105[CrossRef][Medline] [Order article via Infotrieve]
  27. Cozier, G. E., and Anthony, C. (1995) Biochem. J. 312, 679-685
  28. Sode, K., and Sano, H. (1994) Biotechnol. Lett. 16, 455-460
  29. Bolivar, F., Rodriquez, R. L., Greene, P. J., Betlach, M. C., Heyneker, H. L., and Boyer, H. W. (1977) Gene (Amst.) 2, 95-113[Medline] [Order article via Infotrieve]
  30. Chang, A. C. Y., and Cohen, S. N. (1978) J. Bacteriol. 134, 1141-1156[Abstract/Free Full Text]
  31. Vieira, J., and Messing, J. (1987) Methods Enzymol. 153, 3-11[Medline] [Order article via Infotrieve]
  32. Miller, J. H. (1992) A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  33. Saier, M. H., Jr., and Roseman, S. (1972) J. Biol. Chem. 247, 972-975[Abstract/Free Full Text]
  34. Manayan, R., Tenn, G., Yee, H. B., Desai, J. D., Yamada, M., and Saier, M. H., Jr. (1988) J. Bacteriol. 170, 1290-1296[Abstract/Free Full Text]
  35. Matsudaira, P. (1987) J. Biol. Chem. 262, 10035-10038[Abstract/Free Full Text]
  36. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  37. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467[Abstract/Free Full Text]
  38. Yanisch-Perron, C., Vieira, J., and Messing, J. (1985) Gene (Amst.) 33, 103-119[CrossRef][Medline] [Order article via Infotrieve]
  39. Ameyama, M., Nonobe, M., Shinagawa, E., Matsushita, K., Takimoto, K., and Adachi, O. (1986) Agri. Biol. Chem. 50, 49-57
  40. Dulley, J. R., and Grieve, P. A. (1975) Anal. Biochem. 64, 136-141[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Mustafa, C. T. Migita, Y. Ishikawa, K. Kobayashi, S. Tagawa, and M. Yamada
Menaquinone as Well as Ubiquinone as a Bound Quinone Crucial for Catalytic Activity and Intramolecular Electron Transfer in Escherichia coli Membrane-bound Glucose Dehydrogenase
J. Biol. Chem., October 17, 2008; 283(42): 28169 - 28175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Mustafa, Y. Ishikawa, K. Kobayashi, C. T. Migita, M. D. Elias, S. Nakamura, S. Tagawa, and M. Yamada
Amino Acid Residues Interacting with Both the Bound Quinone and Coenzyme, Pyrroloquinoline Quinone, in Escherichia coli Membrane-bound Glucose Dehydrogenase
J. Biol. Chem., August 8, 2008; 283(32): 22215 - 22221.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
MD. Elias, S. Nakamura, C. T. Migita, H. Miyoshi, H. Toyama, K. Matsushita, O. Adachi, and M. Yamada
Occurrence of a Bound Ubiquinone and Its Function in Escherichia coli Membrane-bound Quinoprotein Glucose Dehydrogenase
J. Biol. Chem., January 23, 2004; 279(4): 3078 - 3083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
MD. Elias, M. Tanaka, M. Sakai, H. Toyama, K. Matsushita, O. Adachi, and M. Yamada
C-terminal Periplasmic Domain of Escherichia coli Quinoprotein Glucose Dehydrogenase Transfers Electrons to Ubiquinone
J. Biol. Chem., December 14, 2001; 276(51): 48356 - 48361.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
T. Nitta, H. Nagamitsu, M. Murata, H. Izu, and M. Yamada
Function of the sigma E Regulon in Dead-Cell Lysis in Stationary-Phase Escherichia coli
J. Bacteriol., September 15, 2000; 182(18): 5231 - 5237.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M D. Elias, M. Tanaka, H. Izu, K. Matsushita, O. Adachi, and M. Yamada
Functions of Amino Acid Residues in the Active Site of Escherichia coli Pyrroloquinoline Quinone-Containing Quinoprotein Glucose Dehydrogenase
J. Biol. Chem., March 15, 2000; 275(10): 7321 - 7326.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, M.
Right arrow Articles by Adachi, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, M.
Right arrow Articles by Adachi, O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement